NCT05691478 2026-03-19
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
National Cancer Institute (NCI)
Phase 2/3 Recruiting
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)